DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor.

Source:http://linkedlifedata.com/resource/pubmed/id/16040807

Proc. Natl. Acad. Sci. U.S.A. 2005 Aug 2 102 31 10846-51

Download in:

View as

Triples

General Info

PMID
16040807